Skip to main content

Table 2 Agreement between [123I]FP-CIT and [18F]FE-PE2I

From: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism

  1. PS Parkinsonian syndromes
  2. Measurement of agreement kappa: 0.85 [95% C.I.: 0.76–0.94]. Agreement of normal vs abnormal, kappa: 0.92 [95% C.I.: 0.84–1.00]
  3. *No prior structural imaging available and interpretation of vascular changes based on CT performed in combination with PET